Cargando…
Real-Time Survey of Vaccine Safety of the mRNA-1273 SARS-CoV-2 Vaccine in Workplace Vaccination at Keio University
The mRNA-1273 Moderna COVID-19 vaccine was introduced to combat the COVID-19 global pandemic in 2020. Although the safety of the vaccine has been investigated worldwide, real-world safety data is scarce in Japan. An online, real-time survey of adverse events following immunization (AEFIs) with mRNA-...
Autores principales: | Okumura, Kaho, Hara, Azusa, Inada, Isa, Sugiyama, Daisuke, Hoshino, Takahiro, Yakoh, Takahiro, Yokoyama, Hirokazu, Urushihara, Hisashi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9501947/ https://www.ncbi.nlm.nih.gov/pubmed/36146539 http://dx.doi.org/10.3390/vaccines10091461 |
Ejemplares similares
-
Acute Myocarditis Following Vaccination With the First Dose of the mRNA-1273
Vaccine
por: Olagunju, Abdulbaril, et al.
Publicado: (2022) -
Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/2014 season: application of a doubly robust method to a large-scale, real-world dataset
por: Shibata, Natsumi, et al.
Publicado: (2019) -
Correction to: Influenza vaccination effectiveness for people aged under 65 years in Japan, 2013/ 2014 season: application of a doubly robust method to a large-scale, real-world dataset
por: Shibata, Natsumi, et al.
Publicado: (2019) -
Vaccine-induced immune thrombocytopenia and thrombosis after mRNA-1273 booster vaccination
por: Langerak, T., et al.
Publicado: (2022) -
Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine
por: Wu, Kai, et al.
Publicado: (2021)